Ono Pharmaceutical Co., LTD (Formerly Ono Pharma USA)
Pharmaceutical Company
Based in MA
🤖
AI Overview
With $260K in lobbying spend across 16 quarterly filings, Ono Pharmaceutical Co., LTD (Formerly Ono Pharma USA) is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2022 to 2025.
$260K
Total Spend
4
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $50K |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $210K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
- •Administrative and legislative monitoring and outreach relating to prescription drug pricing reform. Administrative and legislative monitoring and outreach relating to FDA user fee reauthorization.
- •Legislative and regulator actions relating to drug approvals Issues relating to Pharmaceutical Manufacturing and Development
- •Monitor administrative and legislative action affecting FDA drug approvals
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.